The role of DNA breaks in genomic instability and tumorigenesis

被引:301
作者
Mills, KD
Ferguson, DO
Alt, FW
机构
[1] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA
[2] Ctr Blood Res, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1034/j.1600-065X.2003.00060.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DNA double-strand breaks (DSBs) represent dangerous chromosomal lesions that can lead to mutation, neoplastic transformation, or cell death. DSBs can occur by extrinsic insult from environmental sources or may occur intrinsically as a result of cellular metabolism or a genetic program. Mammalian cells possess potent and efficient mechanisms to repair DSBs, and thus complete normal development as well as mitigate oncogenic potential and prevent cell death. When DSB repair (DSBR) fails, chromosomal instability results and can be associated with tumor formation or progression. Studies of mice deficient in various components of the non-homologous end joining pathway of DSBR have revealed key roles in both the developmental program of B and T lymphocytes as well as in the maintenance of general genome stability. Here, we review the current thinking about DSBs and DSBR in chromosomal instability and tumorigenesis, and we highlight the implications for understanding the karyotypic features associated with human tumors.
引用
收藏
页码:77 / 95
页数:19
相关论文
共 201 条
[41]   Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase [J].
Di Noia, J ;
Neuberger, MS .
NATURE, 2002, 419 (6902) :43-48
[42]   Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification [J].
Difilippantonio, MJ ;
Petersen, S ;
Chen, HT ;
Johnson, R ;
Jasin, M ;
Kanaar, R ;
Ried, T ;
Nussenzweig, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (04) :469-480
[43]   DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation [J].
Difilippantonio, MJ ;
Zhu, J ;
Chen, HT ;
Meffre, E ;
Nussenzweig, MC ;
Max, EE ;
Ried, T ;
Nussenzweig, A .
NATURE, 2000, 404 (6777) :510-514
[44]   Chromosome aberrations in B-cell chronic lymphocytic leukemia:: reassessment based on molecular cytogenetic analysis [J].
Döhner, H ;
Stilgenbauer, S ;
Döhner, K ;
Bentz, M ;
Lichter, P .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (02) :266-281
[45]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[46]  
Duan ZG, 2002, CANCER EPIDEM BIOMAR, V11, P1142
[47]   Evaluation of ETF1/eRF1, mapping to 5q31, as a candidate myeloid tumor suppressor gene [J].
Dubourg, C ;
Toutain, B ;
Hélias, C ;
Henry, C ;
Lessard, M ;
Le Gall, JT ;
Le Treut, A ;
Guenet, L .
CANCER GENETICS AND CYTOGENETICS, 2002, 134 (01) :33-37
[48]   Functional interaction between DNA-PKcs and telomerase in telomere length maintenance [J].
Espejel, S ;
Franco, S ;
Sgura, A ;
Gae, D ;
Bailey, SM ;
Taccioli, GE ;
Blasco, MA .
EMBO JOURNAL, 2002, 21 (22) :6275-6287
[49]   Mechanisms of disease - The biology of chronic myeloid leukemia [J].
Faderl, S ;
Talpaz, M ;
Estrov, Z ;
O'Brien, S ;
Kurzrock, R ;
Kantarjian, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :164-172
[50]   Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry [J].
Falini, B ;
Mason, DY .
BLOOD, 2002, 99 (02) :409-426